Business Description
Alzinova AB
ISIN : SE0007413455
Total Employee Number:
7Compare
Compare
Traded in other countries / regions
ALZ.Sweden78D.Germany IPO Date
2015-11-25Description
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is developing ALZ-101, an oligomer-specific therapeutic vaccine currently advancing toward Phase 2 clinical development, and ALZ-201, a monoclonal antibody targeting toxic amyloid-beta (AB) oligomers, which is in preclinical development. The company's proprietary ABCC peptide technology is focused on disease-modifying treatments for Alzheimer's disease.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 14.23 | |||||
Equity-to-Asset | 0.94 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17.8 | |||||
3-Year EPS without NRI Growth Rate | 16.8 | |||||
3-Year FCF Growth Rate | 25.1 | |||||
3-Year Book Growth Rate | -23.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 84.63 | |||||
9-Day RSI | 74.72 | |||||
14-Day RSI | 66.23 | |||||
3-1 Month Momentum % | -21.05 | |||||
6-1 Month Momentum % | -43.29 | |||||
12-1 Month Momentum % | -70.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.37 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 1.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37.6 | |||||
Shareholder Yield % | -64.84 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -20.36 | |||||
ROA % | -18.67 | |||||
ROIC % | -17.33 | |||||
3-Year ROIIC % | -16.06 | |||||
ROCE % | -18.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 18.29 | |||||
PB Ratio | 0.57 | |||||
Price-to-Tangible-Book | 27.25 | |||||
EV-to-EBIT | -4.52 | |||||
EV-to-EBITDA | -4.52 | |||||
EV-to-Forward-Revenue | 3.15 | |||||
EV-to-FCF | -2.25 | |||||
| Price-to-Net-Current-Asset-Value | 27.25 | |||||
| Price-to-Net-Cash | 54.5 | |||||
Earnings Yield (Greenblatt) % | -22.12 | |||||
FCF Yield % | -44.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alzinova AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.27 | ||
| Beta | 0.2528 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.15 | ||
| Volatility % | 73.85 | ||
| 14-Day RSI | 66.23 | ||
| 14-Day ATR (kr) | 0.045043 | ||
| 20-Day SMA (kr) | 0.47905 | ||
| 12-1 Month Momentum % | -70.49 | ||
| 52-Week Range (kr) | 0.382 - 2.28 | ||
| Shares Outstanding (Mil) | 202.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alzinova AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alzinova AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-12 | In 136 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 52 days | ||
| General meeting for 2025 | 2026-05-26 13:00 | 0.48 (+2.89%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 0.41 (-3.46%) | ||
| Annual report for 2025 | 2026-04-23 | 0.58 (+2.30%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 | 0.64 (+1.43%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 1.22 (-5.28%) | ||
| Second quarter earnings results for 2025 | 2025-08-21 | 1.12 (-2.26%) | ||
| General meeting for 2024 | 2025-05-28 13:00 | 1.76 (-2.44%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 1.87 (-2.51%) |
Show
Entries
Alzinova AB Frequently Asked Questions
What is Alzinova AB(OSTO:ALZ)'s stock price today?
The current price of OSTO:ALZ is kr0.55. The 52 week high of OSTO:ALZ is kr2.28 and 52 week low is kr0.38.
When is next earnings date of Alzinova AB(OSTO:ALZ)?
The next earnings date of Alzinova AB(OSTO:ALZ) is 2026-08-20.
Does Alzinova AB(OSTO:ALZ) pay dividends? If so, how much?
Alzinova AB(OSTO:ALZ) does not pay dividend.
Press Release
Articles on Alzinova AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers